Concepedia

Kathleen McKeever

KM

14

Publications

820

Citations

13

H-Index

2003

Active since

Affiliations

Ultragenyx Pharmaceutical (United States)(Current)

Charles River Laboratories (United States)

Kathleen McKeever is an author at Ultragenyx Pharmaceutical (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

MedicineImmunologyImmunotherapyAutoimmunityAutoimmune DiseasePathologyCell DeathCell BiologyPharmacologyDrug Resistance

Publications per year

2003–2022

14

Publications

14

Humanization of a recombinant monoclonal antibody to produce a therapeutic HER dimerization inhibitor, pertuzumab

Camellia Adams, David E. Allison, Kelly M. Flagella et al. · Cancer Immunology Immunotherapy · 2005 · 312 citations · Full text

Recombinant Monoclonal Antibody, Medicine, Immunology +6

Depletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis

Yulia Vugmeyster, Joseph C. Beyer, Kathy Howell et al. · Journal of Immunotherapy · 2005 · 79 citations

Laboratory Immunology, Humoral Response, Immunology +17

Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study

Elena Schiopu, Soumya Chatterjee, Vivien Hsu et al. · Arthritis Research & Therapy · 2016 · 78 citations · Full text

Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys

Anu Vaidyanathan, Kathleen McKeever, Banmeet Anand et al. · Toxicological Sciences · 2010 · 64 citations · Full text

Maternal Immunization, Rituximab Iv, Developmental Biology +15

The Plasma Cell Signature in Autoimmune Disease

Katie Streicher, Christopher Morehouse, Christopher J. Groves et al. · Arthritis & Rheumatology · 2013 · 61 citations

Rows per page

1–5 of 14